125 related articles for article (PubMed ID: 22200536)
1. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.
Lemarié F; Croft DR; Tate RJ; Ryan KM; Dufès C
Biomaterials; 2012 Mar; 33(9):2701-9. PubMed ID: 22200536
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.
Koppu S; Oh YJ; Edrada-Ebel R; Blatchford DR; Tetley L; Tate RJ; Dufès C
J Control Release; 2010 Apr; 143(2):215-21. PubMed ID: 19944722
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain.
Somani S; Blatchford DR; Millington O; Stevenson ML; Dufès C
J Control Release; 2014 Aug; 188():78-86. PubMed ID: 24933602
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex.
Somani S; Robb G; Pickard BS; Dufès C
J Control Release; 2015 Nov; 217():235-42. PubMed ID: 26362697
[TBL] [Abstract][Full Text] [Related]
5. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
Emmrich S; Wang W; John K; Li W; Pützer BM
Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
[TBL] [Abstract][Full Text] [Related]
6. A combination treatment with SAHA and ad-p63/p73 shows an enhanced anticancer effect in HNSCC.
Shim SH; Lee CT; Lee JJ; Kim SY; Hah JH; Heo DS; Sung MW
Tumour Biol; 2010 Dec; 31(6):659-66. PubMed ID: 20665144
[TBL] [Abstract][Full Text] [Related]
7. Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.
Altwaijry N; Somani S; Parkinson JA; Tate RJ; Keating P; Warzecha M; Mackenzie GR; Leung HY; Dufès C
Drug Deliv; 2018 Nov; 25(1):679-689. PubMed ID: 29493296
[TBL] [Abstract][Full Text] [Related]
8. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.
Lim LY; Koh PY; Somani S; Al Robaian M; Karim R; Yean YL; Mitchell J; Tate RJ; Edrada-Ebel R; Blatchford DR; Mullin M; Dufès C
Nanomedicine; 2015 Aug; 11(6):1445-54. PubMed ID: 25933695
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
Das S; Somasundaram K
Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.
Al Robaian M; Chiam KY; Blatchford DR; Dufès C
Nanomedicine (Lond); 2014 Apr; 9(4):421-34. PubMed ID: 24910874
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated TA-p73beta gene transfer increases chemosensitivity of human malignant melanomas.
Tuve S; Racek T; Niemetz A; Schultz J; Soengas MS; Pützer BM
Apoptosis; 2006 Feb; 11(2):235-43. PubMed ID: 16502261
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol.
Karim R; Somani S; Al Robaian M; Mullin M; Amor R; McConnell G; Dufès C
J Control Release; 2017 Jan; 246():79-87. PubMed ID: 27993600
[TBL] [Abstract][Full Text] [Related]
13. Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.
Sakpakdeejaroen I; Somani S; Laskar P; Mullin M; Dufès C
Int J Nanomedicine; 2021; 16():2615-2631. PubMed ID: 33854311
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.
Ma Y; Yu WD; Hershberger PA; Flynn G; Kong RX; Trump DL; Johnson CS
Mol Cancer Ther; 2008 Sep; 7(9):3047-55. PubMed ID: 18790784
[TBL] [Abstract][Full Text] [Related]
15. Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration.
Fu JY; Zhang W; Blatchford DR; Tetley L; McConnell G; Dufès C
J Control Release; 2011 Aug; 154(1):20-6. PubMed ID: 21539872
[TBL] [Abstract][Full Text] [Related]
16. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
Das S; Nama S; Antony S; Somasundaram K
Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
[TBL] [Abstract][Full Text] [Related]
17. Prenyl Ammonium Salts--New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
Grecka E; Statkiewicz M; Gorska A; Biernacka M; Grygorowicz MA; Masnyk M; Chmielewski M; Gawarecka K; Chojnacki T; Swiezewska E; Malecki M
PLoS One; 2016; 11(4):e0153633. PubMed ID: 27088717
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
[TBL] [Abstract][Full Text] [Related]
19. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.
Fu JY; Blatchford DR; Tetley L; Dufès C
J Control Release; 2009 Dec; 140(2):95-9. PubMed ID: 19709637
[TBL] [Abstract][Full Text] [Related]
20. PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa.
Saha MN; Jiang H; Yang Y; Reece D; Chang H
Mol Cancer Ther; 2013 Nov; 12(11):2331-41. PubMed ID: 24030633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
